Category Archives: Healthcare

New Buy Rating for AstraZeneca (AZN), the Healthcare Giant

BMO Capital analyst Alex Arfaei maintained a Buy rating on AstraZeneca (AZN – Research Report) yesterday and set a price target of $48. The company’s shares closed yesterday at $36.11. According to TipRanks.com, Arfaei is a 5-star analyst with an

Credit Suisse Thinks Aimmune Therapeutics’ Stock is Going to Recover

In a report released yesterday, Vamil Divan from Credit Suisse maintained a Buy rating on Aimmune Therapeutics (AIMT – Research Report), with a price target of $40. The company’s shares closed yesterday at $23.73, close to its 52-week low of

Jefferies Reiterates a Buy Rating on Petiq Inc (PETQ)

In a report released today, Kevin Grundy from Jefferies reiterated a Buy rating on Petiq Inc (PETQ – Research Report), with a price target of $39. The company’s shares opened today at $24.63. Grundy said: “PETQ remains our top small-cap

Inovio Pharmaceuticals (INO) Gets a Buy Rating from Maxim Group

Maxim Group analyst Jason McCarthy maintained a Buy rating on Inovio Pharmaceuticals (INO – Research Report) today and set a price target of $8. The company’s shares opened today at $4.55. McCarthy commented: “Inovio announced the publication of a preclinical

Cowen & Co. Reaffirms Their Buy Rating on Esperion (ESPR)

In a report released today, Chris Shibutani from Cowen & Co. maintained a Buy rating on Esperion (ESPR – Research Report), with a price target of $94. The company’s shares opened today at $42.68. According to TipRanks.com, Shibutani is a

Krystal Biotech Inc (KRYS) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Krystal Biotech Inc (KRYS – Research Report) today and set a price target of $32. The company’s shares opened today at $25.10. Pantginis said: “Valuation and risks to price target